Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, today announced that it will be attending the World Agri-Tech Innovation Summit from March 22-23, 2022 in San Francisco.
The World Agri-Tech Innovation Summit has become the annual meeting place for the global agtech ecosystem over the past decade. Growers, agribusiness leaders, technology pioneers and investors come together at the summit to exchange insights and identify future partners.
In attendance will be Evogene’s CEO, Mr. Ofer Haviv, Chief Product Officer, Dr. Nir Arbel, Mr. Dotan Borenstein, Chief Business Officer of Evogene subsidiary Lavie Bio, Mr. Russel Putland, Vice President Commercial of Lavie Bio, and Mr. Brian Ember, CEO of Evogene subsidiary AgPlenus.
Investors that wish to meet with members of management at the conference may contact Evogene’s investor relations team which will coordinate a meeting.
